Company Information
- CEO
- Ernest Loumaye
- Investor Relations
- Mario Corso
ObsEva is a clinical-stage biopharmaceutical company focused on the clinical development and commercialization of novel therapeutics for serious conditions that compromise a woman's reproductive health and pregnancy. Through strategic in-licensing and disciplined drug development, ObsEva has established a late-stage clinical pipeline with four development programs focused on treating endometriosis, uterine fibroids, preterm labor and improving IVF outcomes. The senior management team of ObsEva, led by CEO and co-founder Dr. Ernest Loumaye, possesses extensive experience in the clinical development and registration of pharmaceutical products, with particular emphasis in the field of womens health, fertility and pregnancy. For more information, please visit www.ObsEva.com.
Trading Information
- Sector
- Health Care - 4500
- Regulatory Standard
- International Reporting Standard
- Security Number
- 34617770
- ISIN
- CH0346177709
- Symbol
- OBSN
- Index member
- SPI (SMALL)/SPI ex SLI/SPI Extra/SXI Life Sciences/SXI Bio+Medtech/Swiss All Share
Intermediaries
- Listing Agent
- Lenz & Stähelin
- Lead Bank
- Credit Suisse
- Auditor
- PricewaterhouseCoopers
Information on the Issue
| Security Details | |
|---|---|
| First Listing | 13.07.2018 |
| Class of Share | Action nominative |
| Nominal Value | 0.076923 CHF |
| Total Shares outstanding (post issue; incl. Greenshore - if any) | 45381252 |
| Allocation Details | |
|---|---|
| Primary Shares | n/a |
| Secondary Shares | n/a |
| Primary Greenshoe | n/a |
| Secondary Greenshoe | n/a |
| Greenshoe Details | |
|---|---|
| Executed | n/a |
| Ex-date | 30.11.2002 |
| Executed number of shares | n/a |
| First Trading Day Details | |
|---|---|
| First Trading | 13.07.2018 |
| Price Range | n/a |
| Issue Price | 15.00 CHF |
| First Open | 15.50 CHF |
| First Close | 20.00 CHF |
| Transaction size in Mio. (incl. executed Greenshoe) | n/a |
| Market Capitalisation in Mio. (based on first closing price) | 908 CHF |
Financial Statement
| Number of Employees | 38.4 as per 30.06.2018 |
| Net Revenues in Mio. | n/a |
| Net Gain in Mio. | n/a |